| [1] |
Wang H, Lu Z, Zhao X. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer[J]. J Hematol Oncol, 2019, 12(1):133.
|
| [2] |
谈艳芳，刘利洪，袁成良. AFP、AFP-L3/AFP、PIVKA-Ⅱ联合检测对原发性肝癌的诊断价值[J]. 检验医学与临床, 2021, 18(20):2970-2972.
|
| [3] |
李叶晟，杨宗国，陈晹, 等. 肝癌血清外泌体环状RNA表达谱差异及其临床意义[J]. 肝胆胰外科杂志, 2022, 34(5):283-287.
|
| [4] |
孟俊，王俊青，费晓春, 等. 血浆外泌体circRNA诊断HCC联合检测模型的建立与验证[J]. 检验医学, 2022, 37(1):1-10.
|
| [5] |
张娇弟，马梦婷，张倩, 等. 肝癌来源的外泌体中miRNA的作用[J]. 检验医学与临床, 2022, 19(19):2725-2728.
|
| [6] |
Li X, Li C, Zhang L, et al. The significance of exosomes in the development and treatment of hepatocellular carcinoma[J]. Mol Cancer, 2020, 19(1):1.
|
| [7] |
Abudoureyimu M, Zhou H, Zhi Y, et al. Recent progress in the emerging role of exosome in hepatocellular carcinoma[J]. Cell Prolif, 2019, 52(2):e12541.
|
| [8] |
Wu Q, Zhou L, Lv D, et al. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression[J]. J Hematol Oncol, 2019, 12(1):53.
|
| [9] |
Wang F, Li L, Piontek K, et al. Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma[J]. Hepatology, 2018, 67(3):940-954.
|
| [10] |
Zhou Y, Ren H, Dai B, et al. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts[J]. J Exp Clin Cancer Res, 2018, 37(1):324.
|
| [11] |
Ye L, Zhang Q, Cheng Y, et al. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1 + regulatory B cell expansion[J]. J Immunother Cancer, 2018, 6(1):145.
|
| [12] |
Zhang H, Deng T, Ge S, et al. Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7[J]. Oncogene, 2019, 38(15):2844-2859.
|
| [13] |
Wang H, Hou L, Li A, et al. Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma[J]. Biomed Res Int, 2014: 864894.
|
| [14] |
Suehiro T, Miyaaki H, Kanda Y, et al. Serum exosomal microRNA-122 and microRNA-21 as predictive biomarkers in transarterial chemoembolization-treated hepatocellular carcinoma patients[J]. Oncol Lett, 2018, 16(3):3267-3273.
|
| [15] |
Li J, Li Z, Zheng W, et al. LncRNA-ATB: an indispensable cancer-related long noncoding RNA[J]. Cell Prolif, 2017, 50(6):e12381.
|
| [16] |
Ferrín G, Ranchal I, Llamoza C, et al. Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGE[J]. Liver Int, 2014, 34(3):438-446.
|
| [17] |
Li R, Wang Y, Zhang X, et al. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis[J]. Mol Cancer, 2019, 18(1):18.
|
| [18] |
Lv LH, Wan YL, Lin Y, et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro[J]. J Biol Chem, 2012, 287(19):15874-15885.
|
| [19] |
Chai N, Chang HE, Nicolas E, et al. Properties of subviral particles of hepatitis B virus[J]. J Virol, 2008, 82(16):7812-7817.
|
| [20] |
Masciopinto F, Giovani C, Campagnoli S, et al. Association of hepatitis C virus envelope proteins with exosomes[J]. Eur J Immunol, 2004, 34(10):2834-2842.
|
| [21] |
Shen J, Huang CK, Yu H, et al. The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma[J]. J Cell Mol Med, 2017, 21(5):986-992.
|
| [22] |
Ghafouri-Fard S, Esmaeili M, Taheri M. H19 lncRNA: roles in tumorigenesis[J]. Biomed Pharmacother, 2020, 123: 109774.
|
| [23] |
蒋佳红，李游，邓知敏, 等. 外泌体在肝癌中的应用研究[J]. 医学信息, 2020, 33(24):28-30, 34.
|
| [24] |
Fang JH, Zhang ZJ, Shang LR, et al. Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins[J]. Hepatology, 2018, 68(4):1459-1475.
|
| [25] |
孙文兵，邢艳珑，涂蓉, 等. 肝癌细胞外泌体诱导巨噬细胞M2极化后促进肝癌细胞迁移及侵袭[J]. 中国免疫学杂志, 2022, 38(12):1463-1468.
|
| [26] |
Cheng L, Liu J, Liu Q, et al. Exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through STAT3 pathway in macrophages[J]. Int J Biol Sci, 2017, 13(6):723-734.
|
| [27] |
Nakano T, Chen IH, Wang CC, et al. Circulating exosomal miR-92b: its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence[J]. Am J Transplant, 2019, 19(12):3250-3262.
|
| [28] |
He H, Cao L, Wang Z, et al. Sinomenine relieves airway remodeling by inhibiting epithelial-mesenchymal transition through downregulating TGF-β1 and Smad3 expression in vitro and in vivo[J]. Front Immunol, 2021, 12: 736479.
|
| [29] |
邓敬桓，卢国栋，周静, 等. 晚期转移性肝癌血清外泌体介导TGF-β通路对HepG2细胞上皮间质转化的影响[J]. 中华肿瘤防治杂志, 2023, 30(2):84-92.
|
| [30] |
徐文，郝向芳，李红, 等. 原发性肝癌患者血清诱导人肝癌细胞上皮-间叶间变[J]. 肿瘤, 2008, 28(5):372-377.
|
| [31] |
部楠. 血清肿瘤标志物联合检测在肝癌诊断中的应用价值[J].医疗装备, 2022, 35(12):33-35.
|
| [32] |
李思雯，黄文杰. 肝细胞癌生物标志物的研究进展:对于临床诊断及预后的意义[J]. 内科急危重症杂志, 2023, 29(1):6-10.
|
| [33] |
邹珍珍，王坤，何璐, 等. 异常凝血酶原和甲胎蛋白联合检测在原发性肝癌中的临床价值[J]. 检验医学与临床, 2019, 16(12):1771-1773.
|
| [34] |
屈振，法镇中，汤建军, 等. 肝癌患者血清外泌体内miR-665的表达及临床意义[J]. 肝胆胰外科杂志, 2018, 30(6):453-456.
|
| [35] |
Shi M, Jiang Y, Yang L, et al. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma[J].J Cell Biochem, 2018, 119(6):4711-4716.
|
| [36] |
Liu W, Hu J, Zhou K, et al. Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma[J]. Onco Targets Ther, 2017, 10: 3843-3851.
|
| [37] |
Wang Y, Zhang C, Zhang P, et al. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma[J]. Cancer Med, 2018, 7(5):1670-1679.
|
| [38] |
Cho HJ, Baek GO, Seo CW, et al. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma[J]. Cancer Med, 2020, 9(15):5459-5472.
|
| [39] |
汪晓华，陈晓军. 肝癌患者外周血外泌体mir-25和mir-141表达水平及联合检测诊断效能研究[J]. 中国卫生检验杂志, 2020, 30(4):472-474.
|
| [40] |
Wei Y, Chen X, Liang C, et al. A noncoding regulatory RNAs network driven by circ-CDYL acts specifically in the early stages hepatocellular carcinoma[J]. Hepatology, 2020, 71(1):130-147.
|
| [41] |
Lu Y, Duan Y, Xu Q, et al. Circulating exosome-derived bona fide long non-coding RNAs predicting the occurrence and metastasis of hepatocellular carcinoma[J]. J Cell Mol Med, 2020, 24(2):1311-1318.
|
| [42] |
Lee YR, Kim G, Tak WY, et al. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma[J]. Int J Cancer, 2019, 144(6):1444-1452.
|
| [43] |
Yang L, Peng X, Li Y, et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma[J]. Mol Cancer, 2019, 18(1):78.
|
| [44] |
姜绍文，谢青. 液体活检在肝细胞肝癌早期筛查中的作用及研究进展[J]. 临床内科杂志, 2022, 39(12):802-806.
|
| [45] |
Zhang X, Wang Z, Tang W, et al. Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics[J]. Hepatology, 2022, 76(2):317-329.
|
| [46] |
叶婷丹，雷学忠. 早期肝癌无创诊断之匙——循环游离DNA联合型液体活检[J]. 临床肝胆病杂志, 2022, 38(4):923-926.
|
| [47] |
Varghese J, Kedarisetty C, Venkataraman J, et al. Combination of TACE and sorafenib improves outcomes in BCLC stages B/C of hepatocellular carcinoma: a single centre experience[J]. Ann Hepatol, 2017, 16(2):247-254.
|
| [48] |
Liu W, Zheng L, Zhang R, et al. Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma[J]. Mol Cancer, 2022, 21(1):72.
|
| [49] |
Lou G, Chen L, Xia C, et al. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway[J]. J Exp Clin Cancer Res, 2020, 39(1):4.
|
| [50] |
Fu X, Liu M, Qu S, et al. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway[J]. J Exp Clin Cancer Res, 2018, 37(1):52.
|
| [51] |
Hirao A, Sato Y, Tanaka H, et al. MiR-125b-5p is involved in sorafenib resistance through ataxin-1-mediated epithelial-mesenchymal transition in hepatocellular carcinoma[J]. Cancers, 2021, 13(19):4917.
|
| [52] |
Wang G, Zhao W, Wang H, et al. Exosomal miR-744 inhibits proliferation and sorafenib chemoresistance in hepatocellular carcinoma by targeting PAX2[J]. Med Sci Monit, 2019, 25: 7209-7217.
|
| [53] |
Wu B, Jiang Y, Zhu F, et al. Demethylation effects of elemene on the GSTP1 gene in HCC cell line QGY7703[J]. Oncol Lett, 2016, 11(4):2545-2551.
|
| [54] |
章菊，叶书来，张昌龙, 等. HepG2细胞外泌体冲击树突状细胞介导的抗肿瘤作用[J]. 癌变·畸变·突变, 2019, 31(1):29-34.
|
| [55] |
Qu Z, Wu J, Wu J, et al. Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro[J]. J Exp Clin Cancer Res, 2016, 35(1):159.
|
| [56] |
Takahashi K, Yan IK, Kogure T, et al. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer[J]. FEBS Open Bio, 2014, 4: 458-467.
|
| [57] |
Wang D, Xing N, Yang T, et al. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis[J]. Cancer Med, 2020, 9(19):7218-7230.
|